Researchers discover treatable cause of severe anemia associated with a cancer therapy
Researchers at Mount Sinai Tisch Cancer Center identify a treatable folate deficiency causing severe anemia in some cancer patients receiving PARP inhibitors. Routine folic acid screening could reduce hospitalizations and treatment interruptions.
anemia cancer therapy folate deficiency PARP inhibitors Mount Sinai